Colorectal cancer and high grade dysplasia complicating ulcerative colitis in Italy: A retrospective co-operative IG-IBD study

Digestive and Liver Disease

Volumn 35, Issue 9, 2003, Pages 628-634

  Riegler, G ^a   Bossa, F ^a   Caserta, L ^a   Pera, A ^b   Tonelli, F ^c   Sturniolo, G C ^d   Oliva, L ^e   Contessini Avesani, E ^f   Poggioli, G ^g  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b MAURIZIANO HOSPITAL   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^f FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^g UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Colorectal cancer; Endoscopic surveillance; Ulcerative colitis

Indexed keywords

MESALAZINE; SALAZOSULFAPYRIDINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER LOCALIZATION; CANCER RISK; CANCER SUSCEPTIBILITY; CHI SQUARE TEST; CHILD; CLINICAL FEATURE; COLON RESECTION; COLORECTAL CANCER; CONTROLLED STUDY; DYSPLASIA; ENDOSCOPY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; ILEORECTAL ANASTOMOSIS; ITALY; MAJOR CLINICAL STUDY; MALE; PROCTOCOLECTOMY; RETROSPECTIVE STUDY; ULCERATIVE COLITIS; AGE; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL TUMOR; MIDDLE AGED; MULTICENTER STUDY; ONSET AGE; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COLECTOMY; COLITIS, ULCERATIVE; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 1542394089     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(03)00380-3     Document Type: Article

References (44)

1. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer: a population based study. New Engl J Med 1990;323:1228-33.
2. Wandall EP, Damkier P, Moller Pedersen F, Wilson B, Schaffalitzky de Muckadell OB. Survival and incidence of colorectal cancer in patients with ulcerative colitis in Funen country diagnosed between 1973 and 1993. Scand J Gastroenterol 2000;35:312-7.
3. Riegler G, Carratù R, Tartaglione M, Morace F, Manzione R, Arimoli A. Prevalence and relative risk of malignancy in relatives of Inflammatory bowel disease patients and control subjects. J Clin Gastroenterol 1998;27:211-4.
4. Askling J, Dickman PW, Karlen P, Brostrom O, Lapidus A, Lofberg R, et al. Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study. Lancet 2001;357:262-6.
5. Nuako KW, Ahlquist DA, Mahomey DW, Schaid DJ, Siem DM, Lindor NM. Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study. Gastroenterology 1998;115:1079-83.
6. Lashner BA, Turner BC, Bostwick DG, Frank PH, Hanauer SB. Dysplasia and cancer complicating strictures in ulcerative colitis. Dig Dis Sci 1990;35:349-52.
7. Gumaste V, Sachar DB, Greenstein AJ. Benign and malignant colorectal strictures in ulcerative colitis. Gut 1992;33:938-41.
8. Broome U, Lindberg G, Lofberg R. Primary sclerosing cholangitis in ulcerative colitis-a risk factor for the development of dysplasia and DNA aneuplody? Gastroenterology 1992;102:1877-80.
9. Shetty K, Rybicki L, Brzezinski A, Carey WD, Lashner BA. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 1999;94:1643-9.
10. Nuako KW, Ahlquist DA, Sandborn WJ, Mahoney DW, Siems DM, Zinsmeister AR. Primary sclerosing cholangitis and colorectal carcinoma in patients with chronic ulcerative colitis: a case-control study. Cancer 1998;82:822-6.
11. Agoff SN, Brentnall TA, Crispin DA, Taylor SL, Raaka S, Haggitt RC, et al. The role of cyclooxygenase in ulcerative colitis-associated neoplasia. Am J Pathol 2000;157:737-45.
12. Suzuki S, Sakamoto S, Mitamura T, Sassa S, Kudo H, Yamashita Y. Preventive effects of sulphasalazine on colorectal carcinogenesis in mice with ulcerative colitis. In Vivo 2000;14:463-6.
13. Pinczowski D, Andreas E, Baron J, Yuen J, Adami HO. Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology 1994;107:117-20.
14. Lindberg Bo U, Broomè U, Persson Bo. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulphasalazine. Dis Col Rect 2001;44:77-85.
15. Eaden J, Abrams K, Ekbom A, Jackson E, Mayberry J. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther 2000;14:145-53.
16. Bus PJ, Nagtegaal ID, Verspaget HW, Lamers CB, Geldof H, Van Krieken JH, et al. Mesalazine-induced apoptosis of colorectal cancer: on the verge of a new chemopreventive era? Aliment Pharmacol Ther 1999;13:1397-402.
17. Brentnall TA, Crispin DA, Rabinovitch PS, Haggitt RC, Rubin CE, Stevens AC, et al. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 1994;107:369-78.
18. Riegler G, Cioffi M, Caserta L, Tataglione MT, Vietri MT, D'Auria A, et al. Serum anti-p53 antibodies seem to be related to clinical course of ulcerative colitis Gut 2000:47 (Suppl. III).
19. Rubin CE, Haggit RC, Burmer GC, Brentnall TA, Stevens AC, Levine DS, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992;103:1611-20.
20. Lindberg JO, Stenling RB, Rutegard JN. DNA aneuploidy as a marker of premalignancy in surveillance of patients with ulcerative colitis. Br J Surg 1999;86:947-50.
21. Villa E, Dugani A, Rebecchi AM, Vignoli A, Grottola A, Buttafoco P, et al. Identification of subject at risk for colorectal carcinoma through a test based on K-ras determination in the stoll. Gastroenterology 1997;112(4):1427-8.
22. Itzkowitz SH, Young E, Dubois D, Harpaz N, Bodian C, Chen A, et al. Sialosyl-Tn antigen is prevalent and precedes dysplasia in ulcerative colitis: A retrospective case-control study. Gastroenterol ogy 1996;110:694-704.
23. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994;343:71-4.
24. Riddell R, Goldman H, Ransohoff D, Appleman HD, Fenoglio CM, Haggitt RC, et al. Dysplasia in inflammatory bowel disease: standardised classification with provisional clinical applications. Hum Pathol 1983;14:931-68.
25. Taylor BA, Pembton J, Carpenter HA, Levin KE, Schroeder KW, Welling DR, et al. Dyspalsia in chronic ulcerative colitis, implications for colonoscopic surveillance. Dis Col Rect 1992;35:950-6.
26. Connel WR, Lennard Jones JE, Williams CB, Talbot IC, Price AB, Wilkinson KH. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994;107:934-44.
27. Lennard-Jones J, Ritchie J, Morson B, Williams C. Cancer surveillance in ulcerative colitis. Lancet 1983;11:149-52.
28. Granqvist S, Gabrielsson N, Sundelin P, Thorgeirsson T. Precancerous lesions in the mucosa in ulcerative colitis. A radiographic, endoscopic and histopathologic study. Scand J Gastroenterol 1980;15:289-96.
29. Rosenstock E, Farmer RG, Petras R, Sivak MV, Rankin GB, Sullivan BH. Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 1985;89:1342-6.
30. Lofberg R, Brostom O, Karlern P, Tribukait S, Ost A. Colonoscopic surveillance in long-standing total ulcerative colitis. A 15 year follow-up study. Gastroenterology 1990;99:1021-31.
31. Desaint B, Legendre C, Florent C. Dysplasia and cancer in ulcerative colitis. Hepatogastroenterology 1989;36:219-26.
32. Ullman TA, Loftus EV Jr, Tremaine WJ, Sandborn WJ. Mayo Clinic, Rochester, MN, Fate of Low-Grade Dysplasia in Ulcerative Colitis; AGA 1999; Abstract G2293.
33. Brentnall TA, Bronner MP, Rubin CE, Rabinovitch PS, Kimmey MB, Kowdley KV, et al. Natural history and management of Low-Grade Dysplasia in Ulcerative Colitis; AGA 1999; Abstract G1673.
34. Sequens R. Cancer in the anal canal (transitional zone) after restorative proctocolectomy with stapled ileal pouch-anal anastomosis. Int J Colorectal Dis 1997;12:254-5.
35. Thompson-Fawcett MW, Marcus V, Redston M, Cohen Z, McLeod RS. Risk of dysplasia in long-term ileal pouches and pouches with chronic pouchitis. Gastroenterology 2001;121:275-81.
36. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989;170(Suppl.):2-6.
37. Biasco G, Rossini FP, Hakim R, Brandi G, Di Battista M, Di Febo G, et al. Cancer surveillance in ulcerative colitis: critical analysis of long-term prospective programme. Dig Liver Dis 2002;34:339-42.
38. Tragnone A, Corrao G, Miglio F, Caprilli R, Lanfranchi GA. Incidence of inflammatory bowel disease in Italy: a nationwide population-based study. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Int J Epidemiol 1996;25:1044-52.
39. Karlen P, Lofberg R, Brostrom O, Leijonmarck CE, Hellers G, Persson PJ. Increased risk of cancer in ulcerative colitis: a population-based cohort study. Am J Gastroenterol 1999;94:1047-52.
40. Gilat T, Fireman Z, Grossman A, Hacohen D, Kadish U, Ron E, et al. Colorectal cancer in patients with ulcerative colitis. A population study in central israel. Gastroenterology 1988;94:870-7.
41. Lashner BA, Kane SV, Hanauer SB. Colon cancer surveillance in chronic ulcerative colitis: historicalcohort study. Am J Gastroenterol 1990;85:1083-7.
42. Bianchi AP, Ranzi T. Epidemiologia delle malattie infiammatorie croniche intestinali: uno sguardo nel bacino del mediterraneo. In: Bianchi Porro G, Ardizzone S, editors, IBD year book 1999, Milano: Mediserve; 1999, pp. 1-25.
43. Choi PM, Nugent FW, Schoetz DJ, Silverman ML, Haggitt C. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 1993;105:418-24.
44. Rhodes JM. Surveillance for colitis-associated cancer: we cannot stop now. Dig Liver Dis 2002;34:319-21.